Literature DB >> 28842751

Reply to the letter to the editor: Two-year results of treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.

Masahiro Morimoto1, Hidetaka Matsumoto2, Kensuke Mimura1, Hideo Akiyama1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28842751     DOI: 10.1007/s00417-017-3785-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  INITIAL VERSUS DELAYED PHOTODYNAMIC THERAPY IN COMBINATION WITH RANIBIZUMAB FOR TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY: The Fujisan Study.

Authors:  Fumi Gomi; Yuji Oshima; Ryusaburo Mori; Mariko Kano; Masaaki Saito; Ayana Yamashita; Eiji Iwata; Ruka Maruko
Journal:  Retina       Date:  2015-08       Impact factor: 4.256

2.  [Criteria for diagnosis of polypoidal choroidal vasculopathy].

Authors: 
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2005-07

3.  Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy.

Authors:  Taiichi Hikichi
Journal:  Br J Ophthalmol       Date:  2017-05-25       Impact factor: 4.638

4.  EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Authors:  Adrian Koh; Won Ki Lee; Lee-Jen Chen; Shih-Jen Chen; Yehia Hashad; Hakyoung Kim; Timothy Y Lai; Stefan Pilz; Paisan Ruamviboonsuk; Erika Tokaji; Annemarie Weisberger; Tock H Lim
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

5.  Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.

Authors:  Masahiro Morimoto; Hidetaka Matsumoto; Kensuke Mimura; Hideo Akiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-01       Impact factor: 3.117

6.  Indocyanine green angiographic and optical coherence tomographic findings support classification of polypoidal choroidal vasculopathy into two types.

Authors:  Akiyuki Kawamura; Mitsuko Yuzawa; Ryusaburo Mori; Miho Haruyama; Koji Tanaka
Journal:  Acta Ophthalmol       Date:  2013-07-15       Impact factor: 3.761

7.  Clinical characteristics of exudative age-related macular degeneration in Japanese patients.

Authors:  Ichiro Maruko; Tomohiro Iida; Masaaki Saito; Dai Nagayama; Kuniharu Saito
Journal:  Am J Ophthalmol       Date:  2007-05-23       Impact factor: 5.258

  7 in total
  1 in total

Review 1.  Polypoidal choroidal vasculopathy: An update on current management and review of literature.

Authors:  Amit Harishchandra Palkar; Vikas Khetan
Journal:  Taiwan J Ophthalmol       Date:  2019 Apr-Jun
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.